Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Conventional Loading Dose Ticagrelor in NSTE-ACS
NCT01962428Phase 4Completed
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- Jun 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ticagrelor in non–ST-segment elevation acute coronary syndrome (NSTE-ACS) (2 arms), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoint: Platelet Reactivity Index at 2 hours. Started Jun 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
non–ST-segment elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on NCT01962428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01962428.